These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 26500992)

  • 21. Telogen Effluvium With Dysesthesia (TED) Has Lower B12 Levels and May Respond to B12 Supplementation.
    Daly T; Daly K
    J Drugs Dermatol; 2018 Nov; 17(11):1236-1240. PubMed ID: 30500148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic telogen effluvium: increased scalp hair shedding in middle-aged women.
    Whiting DA
    J Am Acad Dermatol; 1996 Dec; 35(6):899-906. PubMed ID: 8959948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telogen effluvium after allergic contact dermatitis of the scalp.
    Tosti A; Piraccini BM; van Neste DJ
    Arch Dermatol; 2001 Feb; 137(2):187-90. PubMed ID: 11176691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telogen effluvium: a comprehensive review.
    Rebora A
    Clin Cosmet Investig Dermatol; 2019; 12():583-590. PubMed ID: 31686886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent modalities in treatment of telogen effluvium: Comparative study.
    Khattab FM; Rady A; Khashaba SA
    Dermatol Ther; 2022 Oct; 35(10):e15720. PubMed ID: 35851518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expert consensus on the management of Telogen Effluvium in India.
    Mysore V; Parthasaradhi A; Kharkar RD; Ghoshal AK; Ganjoo A; Ravichandran G; Saraswat A; Shah Y; Singh M; Remadevi TJ; Matte P
    Int J Trichology; 2019; 11(3):107-112. PubMed ID: 31360038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID-19 telogen effluvium?
    Koç Yıldırım S; Erbağcı E; Demirel Öğüt N
    J Cosmet Dermatol; 2022 May; 21(5):1809-1815. PubMed ID: 35201647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron status in diffuse telogen hair loss among women.
    Moeinvaziri M; Mansoori P; Holakooee K; Safaee Naraghi Z; Abbasi A
    Acta Dermatovenerol Croat; 2009; 17(4):279-84. PubMed ID: 20021982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted Nutritional Supplementation for Telogen Effluvium: Multicenter Study on Efficacy of a Hydrolyzed Collagen, Vitamin-, and Mineral-Based Induction and Maintenance Treatment.
    Arias EM; Floriach N; Moreno-Arias G; Camps A; Arias S; Trüeb RM
    Int J Trichology; 2022; 14(2):49-54. PubMed ID: 35531488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intermittent Chronic Telogen Effluvium.
    Rebora A
    Skin Appendage Disord; 2017 Mar; 3(1):36-38. PubMed ID: 28612000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NonScarring Diffuse Hair Loss in Women: a Clinico-Etiological Study from tertiary care center in North-West India.
    Poonia K; Thami GP; Bhalla M; Jaiswal S; Sandhu J
    J Cosmet Dermatol; 2019 Feb; 18(1):401-407. PubMed ID: 29774652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffuse hair loss in an adult female: approach to diagnosis and management.
    Shrivastava SB
    Indian J Dermatol Venereol Leprol; 2009; 75(1):20-7; quiz 27-8. PubMed ID: 19172026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Female pattern alopecia and telogen effluvium: figuring out diffuse alopecia.
    Torres F; Tosti A
    Semin Cutan Med Surg; 2015 Jun; 34(2):67-71. PubMed ID: 26176282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telogen effluvium after COVID-19 vaccination among public in Saudi Arabia.
    Alharbi M
    J Family Med Prim Care; 2022 Oct; 11(10):6056-6060. PubMed ID: 36618187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postpartum Telogen Effluvium Unmasking Traction Alopecia.
    Samrao A; Mirmirani P
    Skin Appendage Disord; 2022 Jul; 8(4):328-332. PubMed ID: 35983466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Telogen effluvium. New concepts and review.
    Headington JT
    Arch Dermatol; 1993 Mar; 129(3):356-63. PubMed ID: 8447677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Postpartum Telogen Effluvium Fallacy.
    Mirallas O; Grimalt R
    Skin Appendage Disord; 2016 May; 1(4):198-201. PubMed ID: 27386466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proposing a Simpler Classification of Telogen Effluvium.
    Rebora A
    Skin Appendage Disord; 2016 Sep; 2(1-2):35-38. PubMed ID: 27843920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telogen effluvium in daily practice: Patient characteristics, laboratory parameters, and treatment modalities of 3028 patients with telogen effluvium.
    Yorulmaz A; Hayran Y; Ozdemir AK; Sen O; Genc I; Gur Aksoy G; Yalcin B
    J Cosmet Dermatol; 2022 Jun; 21(6):2610-2617. PubMed ID: 34449961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl.
    Zímová J; Zímová P
    Acta Dermatovenerol Croat; 2016 Jun; 24(2):150-3. PubMed ID: 27477178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.